Spots Global Cancer Trial Database for clinical study
Every month we try and update this database with for clinical study cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Metabolomics Explores Biomarkers for Metastatic Breast Cancer | NCT04302415 | Breast Cancer | There is no oth... | 18 Years - 70 Years | Shandong Cancer Hospital and Institute | |
Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®) | NCT03414489 | Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... | ABC294640 | 18 Years - | RedHill Biopharma Limited | |
Evaluation of a Topical Treatment for Actinic Keratosis | NCT01921907 | Actinic Keratos... | AD17137 topical... Placebo | 30 Years - 90 Years | Assuta Hospital Systems | |
Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies | NCT03682029 | Myelodysplastic... Chronic Myelomo... Cytopenia | Vitamin C (asco... Placebo | 18 Years - | Rigshospitalet, Denmark | |
Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies | NCT03682029 | Myelodysplastic... Chronic Myelomo... Cytopenia | Vitamin C (asco... Placebo | 18 Years - | Rigshospitalet, Denmark | |
Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies | NCT03682029 | Myelodysplastic... Chronic Myelomo... Cytopenia | Vitamin C (asco... Placebo | 18 Years - | Rigshospitalet, Denmark | |
Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®) | NCT03414489 | Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... | ABC294640 | 18 Years - | RedHill Biopharma Limited |